Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.

Item
http://www.wikidata.org/entity/Q34188511
How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.Addressing phenoconversion: the Achilles' heel of personalized medicine.Implications of pharmacogenetics for individualizing drug treatment and for study design.Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients.Pharmacogenetics-based new therapeutic concepts.Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarrayDrug-induced liver graft toxicity caused by cytochrome P450 poor metabolismAlternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues.Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjectsCytochrome P450 polymorphisms and drug-induced interstitial lung disease.Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report.CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humans.Safe and effective medicines for all: is personalized medicine the answer?Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulations.THE EFFECT OF ETHNICITY ON THE INCIDENCE OF POSTOPERATIVE NAUSEA AND VOMITING IN MODERATE TO HIGH RISK PATIENTS UNDERGOING GENERAL ANESTHESIA IN SOUTH AFRICA: A CONTROLLED OBSERVATIONAL STUDY
P2860

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.

Item
http://www.wikidata.org/entity/Q34188511
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@ast
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@en
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@nl
type
label
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@ast
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@en
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@nl
prefLabel
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@ast
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@en
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Pharmacogenetic diagnostics of ...... lopment and in drug treatment.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698